Diabetes mellitus, type 2 Trials in Durban, South Africa
Conditions / Diabetes mellitus, type 2 / Durban, South Africa
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
63 total trials for this combination
Showing top 10 of 63 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | COMPLETED | PHASE3 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT05514535 | A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) | COMPLETED | PHASE3 |
| NCT01959529 | A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events | COMPLETED | PHASE3 |
| NCT01991795 | A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00968708 | Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight | COMPLETED | — |
| NCT01179048 | Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results | COMPLETED | PHASE3 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight | COMPLETED | — |